CIK: 0001549738 · Show all filings
Period: Q3 2018 (← Previous) (Next →)
Filing Date: Nov 9, 2018
Total Value ($000): $185,329 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | CANOPY GROWTH CORP | 1,291,201 | $62,804 | 33.9% | $29.29 | — | COM | 138035100 |
| AMZN | AMAZON COM INC | 19,627 | $39,313 | 21.2% | $34.95 | +169.1% | COM | 023135106 |
| EGRX | EAGLE PHARMACEUTICALS INC | 475,755 | $32,984 | 17.8% | $32.57 | +132.8% | COM | 269796108 |
| CRON | CRONOS GROUP INC | 1,111,444 | $12,351 | 6.7% | $8.41 | +1.0% | COM | 22717L101 |
| — | ANTARES PHARMA INC | 1,920,524 | $6,453 | 3.5% | $2.24 | — | COM | 036642106 |
| — | PETIQ INC | 148,855 | $5,851 | 3.2% | $22.46 | — | COM CL A | 71639T106 |
| — | HORIZON PHARMA PLC | 270,775 | $5,302 | 2.9% | $16.49 | — | SHS | G4617B105 |
| MSFT | MICROSOFT CORP | 41,500 | $4,746 | 2.6% | $55.71 | +80.9% | COM | 594918104 |
| — | BIOSPECIFICS TECHNOLOGIES CO | 73,649 | $4,308 | 2.3% | $50.35 | — | COM | 090931106 |
| ESTA | ESTABLISHMENT LABS HLDGS INC | 160,000 | $3,856 | 2.1% | $25.66 | 0.0% | COM | G31249108 |
| LGND | LIGAND PHARMACEUTICALS INC | 13,401 | $3,678 | 2.0% | $39.89 | +277.9% | COM NEW | 53220K504 |
| — | AVADEL PHARMACEUTICALS PLC | 444,439 | $1,951 | 1.1% | $9.68 | — | SPONSORED ADR | 05337M104 |
| — | NOVELION THERAPEUTICS INC | 315,979 | $935 | 0.5% | $8.44 | — | COM NEW | 67001K202 |
| — | ALIMERA SCIENCES INC | 413,300 | $405 | 0.2% | $1.40 | — | COM | 016259103 |
| BBBY | OVERSTOCK COM INC DEL | 10,000 | $277 | 0.1% | $48.07 | -31.8% | COM | 690370101 |
| — | SONOMA PHARMACEUTICALS INC | 40,951 | $60 | 0.0% | $7.17 | — | COM | 83558L105 |
| — | TELIGENT INC NEW | 13,820 | $55 | 0.0% | $8.90 | — | COM | 87960W104 |